Characterization of Enterococcus faecium with Macrolide Resistance and Reduced Susceptibility to Quinupristin/Dalfopristin in a Japanese Hospital: Detection of Extensive Diversity in erm (B)-Regulator Regions
Restricted accessResearch articleFirst published online August, 2013
Characterization of Enterococcus faecium with Macrolide Resistance and Reduced Susceptibility to Quinupristin/Dalfopristin in a Japanese Hospital: Detection of Extensive Diversity in erm (B)-Regulator Regions
Cross-resistance to macrolide, lincosamide, and streptogramin B (MLSB) antibiotics is mainly mediated by the erm (erythromycin ribosome methylation) genes that encode 23S rRNA methylases in enterococi, and various mechanisms are involved in the streptogramin B resistance. Prevalence of MLSB resistance and its genetic mechanisms were analyzed for a total of 159 strains of Enterococcus faecium isolated from clinical specimens in a university hospital in Japan from 1997 to 2006. Resistance to erythromycin (EM) and clindamycin was detected in 88.1% and 89.9% of all the strains examined, respectively, and expression of resistance was totally constitutive. Although none of the strain was resistant to quinupristin/dalfopristin (Q/D), 28 strains (17.6%) showed intermediate resistance to Q/D (MIC: 2 μg/ml). The erm(B) gene was detected in 139 strains (87.4%), and msrC was found in all the strains examined, whereas no other known MLSB resistance genes were identified. The erm(B) regulator region (RR) containing a coding region of the leader peptide was classified into 13 genetic variations (L1–L3, M, S1–S7, D, and R genotypes) in 56 strains. However, no relatedness was identified between the erm(B) RR genotype and EM resistance, or reduced susceptibility to Q/D, although most of Q/D-intermediate strains were assigned to the L1, L2, and S1 genotypes. Q/D-intermediate strains were classified into five multiple-locus variable-number tandem-repeat analysis (MLVA) types, including four types of clonal complex (CC)-C1, five sequence types (STs), including four STs of CC-17, and several resistance gene/virulence factor profiles. The present study revealed the occurrence of Q/D-intermediate E. faecium, which are composed of heterogeneous strains in Japan, and more genetic diversity in the erm(B) RRs than those reported previously.
Get full access to this article
View all access options for this article.
References
1.
AriasC.A., MurrayB.E.2012. The rise of the Enterococcus: beyond vancomycin resistance. Nat. Rev. Microbiol., 10:266–278.
2.
BozdoganB., LeclercqR., LozniewskiA., WeberM.1999. Plasmid-mediated coresistance to streptogramins and vancomycin in Enterococcus faecium HM1032. Antimicrob. Agents Chemother., 43:2097–2098.
3.
CamargoI.L., GilmoreM.S., DariniA.L.2006. Multilocus sequence typing and analysis of putative virulence factors in vancomycin-resistant and vancomycin-sensitive Enterococcus faecium isolates from Brazil. Clin. Microbiol. Infect., 12:1123–1130.
4.
CaronF., GoldH.S., WennerstenC.B., FarrisM.G., MoelleringR.C.Jr., EliopoulosG.M.1997. Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium. Antimicrob. Agents Chemother., 41:2749–2753.
5.
[CLSI] Clinical and Laboratory Standards Institute. 2009. Methods for dilution susceptibility tests for bacteria that grow aerobically; approved standard. M7-A88th. Clinical and Laboratory Standards Institute: Wayne, PA.
6.
De GraefE.M., DecostereA., De LeenerE., GoossensH., BaeleM., HaesebrouckF.2007. Prevalence and mechanism of resistance against macrolides, lincosamides, and streptogramins among Enterococcus faecium isolates from food-producing animals and hospital patients in Belgium. Microb. Drug Resist., 13:135–141.
7.
DonabedianS.M., PerriM.B., VagerD., HershbergerE., MalaniP., SimjeeS., Chow JJ., VergisE.N., MuderR.R., GayK., AnguloF.J., BartlettP., ZervosM.J.2006. Quinupristin-dalfopristin resistance in Enterococcus faecium isolates from humans, farm animals, and grocery store meat in the United States. J. Clin. Microbiol., 44:3361–3365.
8.
DepardieuF., PodglajenI., LeclercqR., CollatzE., CourvalinP.2007. Modes and modulations of antibiotic resistance gene expression. Clin. Microbiol. Rev., 20:79–114.
9.
DipersioL.P., DipersioJ.R.2007. Identification of an erm(T) gene in strains of inducibly clindamycin-resistant group B Streptococcus. Diagn. Microbiol. Infect. Dis., 57:189–193.
10.
EatonT.J., GassonM.J.2001. Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl. Environ. Microbiol., 67:1628–1635.
11.
FantinB., LeclercqR., GarryL., CarbonC.1997. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis. Antimicrob. Agents Chemother., 41:931–935.
12.
HomanW.L., TribeD., PoznanskiS., LiM., HoggG., SpalburgE., Van EmbdenJ.D., WillemsR.J.2002. Multilocus sequence typing scheme for Enterococcus faecium. J. Clin. Microbiol., 40:1963–1971.
13.
HorinouchiS., WeisblumB.1980. Posttranscriptional modification of mRNA conformation: mechanism that regulates erythromycin-induced resistance. Proc. Natl. Acad. Sci. U S A., 77:7079–7083.
14.
HoshuyamaT., MoriguchiH., MurataniT., MatsumotoT.2008. Vancomycin-resistant enterococci (VRE) outbreak at a university hospital in Kitakyushu, Japan: case-control studies. J. Infect. Chemother., 14:354–360.
15.
IDWR. Surveillance data table, category V (notifiable disease). Infectious Disease Surveillance Center, National Institute of Infectious Disease. www.nih.go.jp/niid/ja/idwr/2085-ydata/1615-report-ja.html. (In Japanese) (Online.)
16.
JacksonC.R., Fedorka-CrayP.J., BarrettJ.B., HiottL.M., WoodleyT.A.2007. Prevalence of streptogramin resistance in enterococci from animals: identification of vatD from animal sources in the USA. Int. J. Antimicrob. Agents., 30:60–66.
17.
JensenL.B., HammerumA.M., AerestrupF.M., van den BogaardA.E., StobberinghE.E.1998. Occurrence of satA and vgb genes in streptogramin-resistant Enterococcus faecium isolates of animal and human origins in the Netherlands. Antimicrob. Agents Chemother., 42:3330–3331.
18.
JensenL.B., HammerumA.M., BagerF., AarestrupF.M.2002. Streptogramin resistance among Enterococcus faecium isolated from production animals in Denmark in 1997. Microb. Drug Resist., 8:369–374.
19.
KaranikaM, PratiA., KiritsiM., SpiliopoulouI., NeonakisI., AnifantakiM., PetinakiE.2008. Reduced susceptibility to quinupristin/dalfopristin in Enterococcus faecium in Greece without prior exposure to the agent. Int. J. Antimicrob. Agents., 31:55–57.
20.
KiekeA.L., BorchardtM.A., KiekeB.A., SpencerS.K., VandermauseM.F., SmithK.E., JawahirS.L., BelongiaE.A.Marshfield Enterococcal Study Group. 2006. Use of streptogramin growth promoters in poultry and isolation of streptogramin-resistant Enterococcus faecium from humans. J. Infect. Dis., 194:1200–1208.
21.
KlareK., WernerG., WitteW.2001. Enterococci. Habitats, infections, virulence factors, resistances to antibiotics, transfer of resistance determinants. MuhldorferI., SchaferK.P.Emerging Bacterial Pathogens: Karger, Basel, 108–122.
22.
KobayashiN., WuH., KojimaK., TaniguchiK., UrasawaS., UeharaN., OmizuY., KishiY., YagihashiA., KurokawaI.1994. Detection of mecA, femA, and femB genes in clinical strains of staphylococci using polymerase chain reaction. Epidemiol. Infect., 113:259–266.
23.
LópezF., CulebrasE., BetriúC., Rodríguez-AvialI., GómezM., PicazoJ.J.2010. Antimicrobial susceptibility and macrolide resistance genes in Enterococcus faecium with reduced susceptibility to quinupristin-dalfopristin: level of quinupristin-dalfopristin resistance is not dependent on erm(B) attenuator region sequence. Diagn. Microbiol. Infect. Dis., 66:73–77.
24.
MartinB., AlloingG., MéjeanV., ClaverysJ.P.1987. Constitutive expression of erythromycin resistance mediated by the ermAM determinant of plasmid pAM beta 1 results from deletion of 5′ leader peptide sequences. Plasmid, 18:250–253.
25.
MartineauF., PicardF.J., LansacN., MénardC., RoyP.H., OuelletteM., BergeronM.G.2000. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother., 44:231–238.
26.
MinY-H., JeongJ-H., ChoiY-J., YunH-J., LeeK., ShimM-J., KwakJ-H., ChoiE-C.2003. Heterogeneity of macrolide-lincosamide-streptogramin B resistance phenotypes in enterococci. Antimicrob. Agents Chemother., 47:3415–3420.
27.
MinY-H., KwonA-R., YoonJ-M., YoonE-J., ShimM-J., ChoiE-C.2008. Molecular analysis of constitutive mutations in ermB and ermA selected in vitro from inducibly MLSB-resistant enterococci. Arch. Pharm. Res., 31:377–380.
28.
MurrayB.E.1998. Diversity among multidrug-resistant enterococci. Emerg. Infect. Dis., 4:37–47.
29.
NakajimaY.1999. Mechanisms of bacterial resistance to macrolide antibiotics. J. Infect. Chemother., 5:61–74.
30.
NishimotoY., KobayashiN., AlamM.M., IshinoM., UeharaN., WatanabeN.2005. Analysis of the prevalence of tetracycline resistance genes in clinical isolates of Enterococcus faecalis and Enterococcus faecium in a Japanese hospital. Microb. Drug Resist., 11:146–153.
31.
OhW.-S., KoK.-S., SongJ.-H., LeeM.-Y., ParkS., PeckK.-R., LeeN.-Y., KimC.-K., LeeH., KimS.-W., ChangH.-H., KimY.-S., JungS.-I., SonJ.-S., YeomJ.-S., KiH.-K., WooG.-J.2005. High rate of resistance to quinupristin-dalfopristin in Enterococcus faecium clinical isolates from Korea. Antimicrob. Agents Chemother., 49:5176–5178.
32.
PereiraG.H., MüllerP.R., ZanellaR.C., de Jesus Castro LimaM., TorchioD.S., LevinA.S.Outbreak of vancomycin-resistant enterococci in a tertiary hospital: the lack of effect of measures directed mainly by surveillance cultures and differences in response between Enterococcus faecium and Enterococcus faecalis. Am. J. Infect. Control., 38:406–409.
Rende-FournierR., LeclercqR., GalimandM., DuvalJ., CourvalinP.1993. Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium BM4145. Antimicrob. Agents Chemother., 37:2119–2125.
35.
ReyesJ., HidalgoM., DíazL., RincónS., MorenoJ., VanegasN., CastañedaE., AriasC.A.2007. Characterization of macrolide resistance in Gram-positive cocci from Colombian hospitals: a countrywide surveillance. Int. J. Infect. Dis., 11:329–336.
36.
RosatoA., VicariniH., LeclercqR.1999. Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycin. J. Antimicrob. Chemother., 43:559–562.
37.
SchmitzF.J., SadurskiR., KrayA., BoosM., GeiselR., KöhrerK., VerhoefJ., FluitA.C.2000. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J. Antimicrob. Chemother., 45:891–894.
38.
SchmitzF.J., VerhoefJ., FluitA.C.and Sentry Participants Group. 1999. Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. J. Antimicrob. Chemother., 43:783–792.
39.
SchoutenM.A., VossA., Hoogkamp-KorstanjeJ.A.and the European VRE Study Group. 1999. Antimicrobial susceptibility patterns of enterococci causing infections in Europe. Antimicrob. Agents Chemother., 43:2542–2546.
40.
SinghK.V., MalathumK., MurrayB.E.2001. Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility. Antimicrob. Agents Chemother., 45:263–266.
41.
SoltaniM., BeightonD., Philpott-HowardJ., WoodfordN.2000. Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in Western Europe. Antimicrob. Agents Chemother., 44:433–436.
42.
Tait-KamradtA., DaviesT., CronanM., JacobsM.R., AppelbaumP.C., SutcliffeJ.2000. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother., 44:2118–2125.
43.
TopJ., SchoulsL.M., BontenM.J., WillemsR.J.2004. Multiple-locus variable-number tandem repeat analysis, a novel typing scheme to the genetic relatedness and epidemiology of Enterococcus faecium isolates. J. Clin. Microbiol., 42:4503–4511.
44.
TopJ., WillemsR., BontenM.2008. Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS. Immunol. Med. Microbiol., 52:297–308.
45.
WatanabeS., KobayashiN., QuiñonesD., NagashimaS., UeharaN., WatanabeN.2009. Genetic diversity of enterococci harboring the high-level gentamicin resistance gene aac(6')-Ie-aph(2'')-Ia or aph(2'')-Ie in a Japanese hospital. Microb. Drug Resist., 15:185–194.
46.
WernerG., HildebrandtB., WitteW.2001. The newly described msrC gene is not equally distributed among all isolates of Enterococcus faecium. Antimicrob. Agents Chemother., 45:3672–3673.
47.
WernerG., KlareI., HeierH., HinzK.H., BöhmeG., WendtM., WitteW.2000. Quinupristin/dalfopristin-resistant enterococci of the satA (vatD) and satG (vatE) genotypes from different ecological origins in Germany. Microb. Drug Resist., 6:37–47.
48.
WernerG., KlareI., SpenckerF.B., WitteW.2003. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital. J. Antimicrob. Chemother., 52:113–115.
49.
WernerG., KlareI., WitteW.2002. Molecular analysis of streptogramin resistance in enterococci. Int. J. Med. Microbiol., 292:81–94.
50.
WernerG., KlareI., WitteW.2007. The current MLVA typing scheme for Enterococcus faecium is less discriminatory than MLST and PFGE for epidemic-virulent, hospital-adapted clonal types. BMC Microbiol., 7:28.
51.
WernerG., WitteW.1999. Characterization of a new enterococcal gene, satG, encoding a putative acetyltransferase conferring resistance to Streptogramin A compounds. Antimicrob. Agents Chemother., 43:1813–1814.
52.
WondrackL., MassaM., YangB.V., SutcliffeJ.1996. Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob. Agents Chemother., 40:992–998.
53.
YamaguchiK., OhnoA., IshiiY., TatedaK., IwataM.and levofloxacin-surveillance group. 2009. In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007. Jpn. J. Antibiot., 62:346–370.
54.
YilmazG., AydinK., IskenderS., CaylanR., KoksalI.2007. Detection and prevalence of inducible clindamycin resistance in staphylococci. J. Med. Microbiol., 56:342–345.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
